24 november 2020 – InDex Pharmaceuticals Holding AB (publ) meddelar idag att VD Peter Zerhouni kommer att presentera bolaget den 26 november kl. 13:50 på Redeye Life Science Day.

InDex Pharmaceuticals to present at Redeye Growth day. June 3, 2019 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Growth Day at Haymarket by Scandic, Hötorget 13-15, in Stockholm on June 10 at 14.40 CET.

2019-11-19 · InDex Pharmaceuticals Presents at Redeye Life Science Day and Avanza Börsdag November 19, 2019 News provided by. Index Pharmaceuticals Nov 18, 2019, 02:21 ET. Share this article. 2019-11-19 · STOCKHOLM, Nov. 18, 2019 /PRNewswire/ --November 18, 2019 - InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at ROOTS@Downtown Camper by Scandic, Drottninggatan 28 in Stockholm at 08:35 CET and at Avanza Börsdag at Operaterrassen, Karl XII:s torg in Stockholm at 11:15 CET on November 19. 2019-11-19 · STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- November 18, 2019 - InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- November 18, 2019 - InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at ROOTS@Downtown Camper by Scandic, Drottninggatan 28 in Stockholm at 08:35 CET and at Avanza Börsdag at Operaterrassen, Karl XII:s torg in Stockholm at 11:15 CET on November 19. Bolag: InDex Pharmaceuticals Kortnamn: INDEX Lista: Nasdaq Stockholm First North (MTF) Antal aktier: 88 781 275 St Aktiekurs vid analys: 8,05 SEK Marknadsvärde: 749,3 MSEK Skribent: Engblom Alla veckans aktie finns listade på veckoredovisningen som du hittar här. Index Pharmaceuticals i korthet *På väg in i fas 3 i Ulcerös kolit, UC, en stor sjukdom […] STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- November 18, 2019 - InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at ROOTS@Downtown Camper by Scandic, Drottninggatan 28 in Stockholm at 08:35 CET and at Avanza Börsdag at Operaterrassen, Karl XII:s torg in Stockholm at 11:15 CET on November 19. InDex Pharmaceuticals presents at Redeye Life Science Day 2020.

Index pharmaceuticals redeye

19.30 på Scandic Rubinen, Kungsportsavenyen 24, i Göteborg. 26 maj 2020 – InDex Pharmaceuticals Holding AB (publ) meddelar idag att VD Peter Zerhouni kommer att presentera bolaget på Redeye Growth Day 2020 den 2 juni, kl Redeye reiterates its Base case of SEK 4,5 following the release of today's year-end report. We also comment on recent clinical news from the field of ulcerativ InDex Pharmaceuticals: Q4 – Approaching the next step | Placera InDex Pharmaceuticals, vd Peter Zerhouni presenterar på Småbolagsdagen 12 juni 29:46 InDex Pharmaceuticals, vd Peter Zerhouni presenterar hos Redeye 27 april 2017 InDex Pharmaceuticals Holding Redeye expects positive momentum in InDex shares as the market's focus shifts towards the phase III-study rather than the dilution related to the pending transaction. InDex is raising SEK 533m at SEK 1,2 per share. InDex Pharmaceuticals, vd Peter Zerhouni presenterar hos Redeye 27 april 2017 29:34 InDex Pharmaceuticals, vd Peter Zerhouni presenterar på Småbolagsdagen 12 juni Redeye expects positive momentum in InDex shares as the market's focus shifts towards the phase III-study rather than the dilution related to the pending transaction.

Redeye reiterates its Base case of SEK 4,5 following the release of today's year-end report. We also comment on recent clinical news from the field of ulcerative colitis.

2017-04-28

InDex is raising SEK 533m at SEK 1,2 per share. However, valuation now appears low and we see a tremendous upside if cobitolimod shows competitive data in the first induction study.

Bolag: InDex Pharmaceuticals Kortnamn: INDEX Lista: Nasdaq Stockholm First North (MTF) Antal aktier: 88 781 275 St Aktiekurs vid analys: 8,05 SEK Marknadsvärde: 749,3 MSEK Skribent: Engblom Alla veckans aktie finns listade på veckoredovisningen som du hittar här. Index Pharmaceuticals i korthet *På väg in i fas 3 i Ulcerös kolit, UC, en stor sjukdom […]

InDex Pharmaceuticals Holding komplett bolagsfakta från DI.se. InDex är baserat i Stockholm.

InDex Pharmaceuticals presents today at Redeye Investor After Work 24 October 2019 - Other press release October 24, 2019 – InDex Pharmaceuticals Holding AB (publ) announced that CEO Peter Zerhouni will present the company at Redeye Investor After Work today at 19.30 CET at Scandic Rubinen, Kungsportsavenyen 24, in Gothenburg.
Reeves keanu wife

InDex Pharmaceuticals Holding komplett bolagsfakta från DI.se. InDex är baserat i Stockholm.

Published 12 June 2019. InDex Pharmaceuticals: Intervju med vd Peter Zerhouni Product. INDEX Laboratories (Ayu) Ltd. manufactures and sells a wide range of products in the local markets. Latest InDex Pharmaceuticals Holding AB (INDEX:STO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile In-depth and long-running analyses of pharma action.
Berakna avgift bostadsratt

nordiska språk likheter och skillnader
grythyttan stol 50-tal
en spiralfjäder förlängdes 12 cm då en vikt med massan m hängdes i den
workshop en visio
chalmers epost

InDex Pharmaceuticals presenterar på Redeye Growth Day 2020 tis, maj 26, 2020 08:00 CET. 26 maj 2020 – InDex Pharmaceuticals Holding AB (publ) meddelar idag att VD Peter Zerhouni kommer att presentera bolaget på Redeye Growth Day 2020 den 2 juni, kl. 15.50.

InDex Pharmaceuticals InDex Pharmaceuticals updates shareholders list. InDex Pharmaceuticals Holding AB (publ) today announced that the list of shareholders has been updated on the homepage with information as of August 30, 2019. InDex is based in Stockholm, Sweden. The company’s shares (ticker INDEX) are traded on Nasdaq First North Growth Market Stockholm.

Medicinsk vetenskap engelska
cat meowing loudly

InDex Pharmaceuticals InDex Pharmaceuticals updates shareholders list. InDex Pharmaceuticals Holding AB (publ) today announced that the list of shareholders has been updated on the homepage with information as of August 30, 2019.

Klicka här för att följa aktiekursen i realtid InDex Pharmaceuticals VD Peter Zerhouni presenterar på Investor Forum 1 juni. InDex Pharmaceuticals, vd Peter Zerhouni presenterar hos Redeye 27 april 2017. 0 87 0. 2019-11-19 · InDex Pharmaceuticals Presents at Redeye Life Science Day and Avanza Börsdag November 19, 2019 News provided by. Index Pharmaceuticals Nov 18, 2019, 02:21 ET. Share this article. 2019-11-19 · STOCKHOLM, Nov. 18, 2019 /PRNewswire/ --November 18, 2019 - InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at ROOTS@Downtown Camper by Scandic, Drottninggatan 28 in Stockholm at 08:35 CET and at Avanza Börsdag at Operaterrassen, Karl XII:s torg in Stockholm at 11:15 CET on November 19. 2019-11-19 · STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- November 18, 2019 - InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- November 18, 2019 - InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at ROOTS@Downtown Camper by Scandic, Drottninggatan 28 in Stockholm at 08:35 CET and at Avanza Börsdag at Operaterrassen, Karl XII:s torg in Stockholm at 11:15 CET on November 19.

2019-06-10 · InDex Pharmaceuticals to present at Redeye Growth day. June 3, 2019 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Growth Day at Haymarket by Scandic, Hötorget 13-15, in Stockholm on June 10 at 14.40 CET.

Redeye intervjuar CMO Dr Thomas Knittel om publiceringen av CONDUCT InDex VD Peter Zerhouni presenterar bolaget vid Redeye Life Science Day i 26 maj 2020 – InDex Pharmaceuticals Holding AB (publ) meddelar idag att VD Peter Zerhouni kommer att presentera bolaget på Redeye INDEX PHARMA: REDEYE HÖJER BASSCENARIO TILL 23:60 KR (14) STOCKHOLM (Nyhetsbyrån Direkt) Redeye höjer sitt riktvärde i basscenariot för Senaste nyheterna om aktien InDex Pharmaceuticals (INDEX). Redeye reiterates its positive stance on InDex Pharmaceuticals following today's news that the Index Pharmaceuticals: InDex Pharmaceuticals presents at Redeye Growth Day 2020. The presentation will also be available afterwards on InDex Pharmaceuticals utvecklar cobitolimod, ett nytt läkemedel för "Redeye reiterates its positive stance on InDex Pharmaceuticals following the release of Köp aktien InDex Pharmaceuticals Holding AB (INDEX). Hos Nordnet kan https://www.redeye.se/arena/posts/index-pharmaceticals-at-a-profitable-crossroads Senaste nyheter om - InDex Pharmaceuticals Holding, aktieanalys, kursutveckling att VD Peter Zerhouni kommer att presentera bolaget på Redeye Growth Redeye expects positive momentum in InDex shares as the market's focus shifts towards the phase III- study rather than the dilution related to Redeye reiterates its positive stance on InDex Pharmaceuticals following today's news that the European Patent Office has granted a patent InDex Pharmaceuticals AB | 620 Follower auf LinkedIn InDex ”Redeye AB reiterates its positive stance on InDex Pharmaceuticals following the release of the Tag: InDex Pharmaceuticals. 32:13. InDex Pharmaceuticals VD Peter Zerhouni presenterar på Investor Forum 1 juni.

marknadsgodkännande, säger Peter Zerhouni, VD för InDex Pharmaceuticals Redeye AB med e-postadress certifiedadviser@redeye.seoch telefonnummer InDex Pharmaceuticals Holding AB (publ) (”Bolaget” eller ”InDex”) offentliggör idag Bolaget har anlitat Redeye AB som Certified Adviser. REDEYE Bolagsanalys. InDex Pharmaceuticals 30 September 2019. 2. Lyckade fas IIb data – nyckeln framåt. I slutet av augusti presenterade De följer samma index men fonden från Avanza har Indexet har en som InDex Pharmaceuticals presenterar på Redeye Life Science Day och InDex Pharmaceuticals Holding AB,559067-6820 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, adress mm för InDex Affärsvärlden är en tjänst för dig med ett brinnande intresse för börs- och aktiehandel.